Author

Mathew Amprayil Cherian

OU HealthORCID 0000-0002-0380-2012Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Barbara Mensah Sankofi· 1 shared Benjamin F. MilleriD· 1 shared Elizabeth A. WellbergiD· 1 shared Haoning Howard CeniD· 1 shared Malika SekhriiD· 1 shared Michael B. StoutiD· 1 shared Michael C. RudolphiD· 1 shared Nisha S. Thomas· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Barbara Mensah Sankofi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Tamoxifen Targets Wisp2 to Impair Subcutaneous Adipocyte Progenitor Self-Renewal and Adipogenic Differentiation

Nisha S. Thomas, Barbara Mensah Sankofi, Haoning Howard Cen, Malika Sekhri, Stevi J. Murguia, Mathew Amprayil Cherian, Michael B. Stout, Benjamin F. Miller, Michael C. Rudolph, Elizabeth A. Wellberg

This study shows tamoxifen reduces subcutaneous adipocyte progenitor self-renewal and adipogenesis by suppressing Wisp2, linking endocrine therapy to metabolic risks like T2D.

Communications Biology · Oct 30, 2026Peer-reviewedCell Biology